385 related articles for article (PubMed ID: 19863495)
1. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
Simrén M; Ohman L; Olsson J; Svensson U; Ohlson K; Posserud I; Strid H
Aliment Pharmacol Ther; 2010 Jan; 31(2):218-27. PubMed ID: 19863495
[TBL] [Abstract][Full Text] [Related]
2. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
4. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
5. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
[TBL] [Abstract][Full Text] [Related]
8. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
10. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ
Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
[TBL] [Abstract][Full Text] [Related]
11. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
14. Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study.
Guyonnet D; Woodcock A; Stefani B; Trevisan C; Hall C
J Dig Dis; 2009 Feb; 10(1):61-70. PubMed ID: 19236549
[TBL] [Abstract][Full Text] [Related]
15. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study.
Guyonnet D; Schlumberger A; Mhamdi L; Jakob S; Chassany O
Br J Nutr; 2009 Dec; 102(11):1654-62. PubMed ID: 19622191
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[TBL] [Abstract][Full Text] [Related]
17. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
Nobaek S; Johansson ML; Molin G; Ahrné S; Jeppsson B
Am J Gastroenterol; 2000 May; 95(5):1231-8. PubMed ID: 10811333
[TBL] [Abstract][Full Text] [Related]
18. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity.
de Vrese M; Kristen H; Rautenberg P; Laue C; Schrezenmeir J
J Dairy Res; 2011 Nov; 78(4):396-403. PubMed ID: 21871144
[TBL] [Abstract][Full Text] [Related]
19. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
